Isolation and Whole-genome Sequence Analysis of the Imipenem Heteroresistant Acinetobacter baumannii Clinical Isolate HRAB-85.

OBJECTIVES Heteroresistance is a phenomenon in which there are various responses to antibiotics from bacterial cells within the same population. Here, we isolated and characterised an imipenem heteroresistant Acinetobacter baumannii strain (HRAB-85). METHODS The genome of strain HRAB-85 was completely sequenced and analysed to understand its antibiotic resistance mechanisms. Population analysis and multilocus sequence typing were performed. RESULTS Subpopulations grew in the presence of imipenem at concentrations of up to 64μg/mL, and the strain was found to belong to ST208. The total length of strain HRAB-85 was 4,098,585bp with a GC content of 39.98%. The genome harboured at least four insertion sequences: the common ISAba1, ISAba22, ISAba24, and newly reported ISAba26. Additionally, 19 antibiotic-resistance genes against eight classes of antimicrobial agents were found, and 11 genomic islands (GIs) were identified. Among them, GI3, GI10, and GI11 contained many ISs and antibiotic-resistance determinants. CONCLUSIONS The existence of imipenem heteroresistant phenotypes in A. baumannii was substantiated in this hospital, and imipenem pressure, which could induce imipenem-heteroresistant subpopulations, may select for highly resistant strains. The complete genome sequencing and bioinformatics analysis of HRAB-85 could improve our understanding of the epidemiology and resistance mechanisms of carbapenem-heteroresistant A. baumannii.

[1]  S. Bridges,et al.  Empirical comparison of ab initio repeat finding programs , 2008, Nucleic acids research.

[2]  S. Eddy,et al.  tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. , 1997, Nucleic acids research.

[3]  Matthew R. Laird,et al.  IslandViewer update: improved genomic island discovery and visualization , 2013, Nucleic Acids Res..

[4]  Stephen Lory,et al.  MobilomeFINDER: web-based tools for in silico and experimental discovery of bacterial genomic islands , 2007, Nucleic Acids Res..

[5]  Xi Li,et al.  Complete genome sequence of Acinetobacter baumannii XH386 (ST208), a multi-drug resistant bacteria isolated from pediatric hospital in China , 2015, Genomics data.

[6]  A. Maniatis,et al.  Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. , 2007, Journal of medical microbiology.

[7]  Z. Deng,et al.  Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors , 2015, Scientific Reports.

[8]  Mihai Pop,et al.  ARDB—Antibiotic Resistance Genes Database , 2008, Nucleic Acids Res..

[9]  A. Maniatis,et al.  Heteroresistance to carbapenems in Acinetobacter baumannii. , 2005, The Journal of antimicrobial chemotherapy.

[10]  J. Pérez-Díaz,et al.  β-Lactam coselection of sensitive and TEM-1 β-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies , 1985 .

[11]  Harald Seifert,et al.  Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.

[12]  Yee-Chun Chen,et al.  Genome Sequence of a Dominant, Multidrug-Resistant Acinetobacter baumannii Strain, TCDC-AB0715 , 2011, Journal of bacteriology.

[13]  M. Valvano,et al.  Antimicrobial Heteroresistance: an Emerging Field in Need of Clarity , 2015, Clinical Microbiology Reviews.

[14]  C.M. Ying,et al.  Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination , 2015, The Journal of Antibiotics.

[15]  S. Pournaras,et al.  Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K. pneumoniae , 2010, Journal of Clinical Microbiology.

[16]  Darren A. Natale,et al.  The COG database: an updated version includes eukaryotes , 2003, BMC Bioinformatics.

[17]  Yonghong Xiao,et al.  Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach , 2016, Scientific Reports.

[18]  A. Zavascki,et al.  Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration. , 2009, Revista do Instituto de Medicina Tropical de Sao Paulo.

[19]  C. Chiu,et al.  Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. , 2011, International journal of antimicrobial agents.

[20]  Peter F. Hallin,et al.  RNAmmer: consistent and rapid annotation of ribosomal RNA genes , 2007, Nucleic acids research.

[21]  S. Rasmussen,et al.  Identification of acquired antimicrobial resistance genes , 2012, The Journal of antimicrobial chemotherapy.

[22]  K. Kaye,et al.  Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management , 2013, Expert review of anti-infective therapy.

[23]  Ibtissem Grissa,et al.  CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats , 2007, Nucleic Acids Res..

[24]  David S. Wishart,et al.  PHAST: A Fast Phage Search Tool , 2011, Nucleic Acids Res..

[25]  S. Pournaras,et al.  Heteroresistance to Meropenem in Carbapenem-Susceptible Acinetobacter baumannii , 2009, Journal of Clinical Microbiology.

[26]  F. Rodríguez-Valera,et al.  Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii , 2005, Journal of Clinical Microbiology.

[27]  M. Borodovsky,et al.  GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. , 2001, Nucleic acids research.

[28]  L. Lutz,et al.  Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa. , 2013, Journal of medical microbiology.

[29]  G. Di Bonaventura,et al.  Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients. , 2009, The Journal of infection.

[30]  U. Kim,et al.  Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections , 2014, Chonnam medical journal.

[31]  Patricia Siguier,et al.  ISfinder: the reference centre for bacterial insertion sequences , 2005, Nucleic Acids Res..

[32]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[33]  F. Baquero,et al.  beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. , 1985, The Journal of antimicrobial chemotherapy.

[34]  R. Cantón,et al.  Carbapenem Heteroresistance in VIM-1-Producing Klebsiella pneumoniae Isolates Belonging to the Same Clone: Consequences for Routine Susceptibility Testing , 2010, Journal of Clinical Microbiology.

[35]  S F Altschul,et al.  Protein database searches for multiple alignments. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Benson,et al.  Tandem repeats finder: a program to analyze DNA sequences. , 1999, Nucleic acids research.

[37]  Qing Yang,et al.  Genomic Analysis of the Multidrug-Resistant Acinetobacter baumannii Strain MDR-ZJ06 Widely Spread in China , 2011, Antimicrobial Agents and Chemotherapy.

[38]  Robert D. Finn,et al.  Rfam: updates to the RNA families database , 2008, Nucleic Acids Res..

[39]  S. Wai,et al.  Novel Aminoglycoside Resistance Transposons and Transposon-Derived Circular Forms Detected in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates , 2016, Antimicrobial Agents and Chemotherapy.

[40]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[41]  A. Maniatis,et al.  Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa. , 2008, FEMS microbiology letters.

[42]  Y. Fukuchi,et al.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin , 1997, The Lancet.

[43]  Z. Zong,et al.  Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study , 2013, BMC Microbiology.

[44]  J. Vila,et al.  Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems. , 2012, International journal of antimicrobial agents.

[45]  J. Sheng,et al.  Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital , 2013, Antimicrobial Agents and Chemotherapy.

[46]  Mamta Sharma,et al.  Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[48]  D. Lipman,et al.  A genomic perspective on protein families. , 1997, Science.

[49]  Wing-Kin Sung,et al.  A Genomic Survey of Positive Selection in Burkholderia pseudomallei Provides Insights into the Evolution of Accidental Virulence , 2010, PLoS pathogens.

[50]  K. Yuen,et al.  Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  A. Marchese,et al.  Heterogeneous Vancomycin Resistance in Methicillin-ResistantStaphylococcus aureus Strains Isolated in a Large Italian Hospital , 2000, Journal of Clinical Microbiology.